AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0061
-0.0009 (-12.86%)
Jul 25, 2025, 3:48 PM EDT

AXIM Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 20192015 - 2019
Period Ending
Jul '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2015 - 2019
255605423
Upgrade
Market Cap Growth
-59.73%-12.57%-91.35%10.19%135.52%-48.38%
Upgrade
Enterprise Value
91011665929
Upgrade
Last Close Price
0.010.020.030.430.430.36
Upgrade
PS Ratio
24.88114.26581.91987.63--
Upgrade
PB Ratio
-0.24-0.59-1.07-25.5434.61-3.40
Upgrade
EV/Sales Ratio
97.83260.761201.771086.71--
Upgrade
Debt / Equity Ratio
-0.71-0.77-1.18-2.894.05-0.75
Upgrade
Asset Turnover
0.020.010.000.01--
Upgrade
Quick Ratio
0.000.030.010.180.310.21
Upgrade
Current Ratio
0.000.030.030.250.480.48
Upgrade
Return on Assets (ROA)
-36.27%-41.26%-60.99%-60.17%-47.56%-102.77%
Upgrade
Return on Capital (ROIC)
---110.15%-81.29%-99.14%-
Upgrade
Earnings Yield
-178.92%-178.50%-120.88%-26.85%-11.83%-28.02%
Upgrade
FCF Yield
-32.96%-22.82%-39.75%-4.23%-6.11%-21.90%
Upgrade
Buyback Yield / Dilution
-27.42%-37.60%-25.79%-19.16%-78.19%-8.14%
Upgrade
Updated Aug 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.